期刊文献+

德国肿瘤预防控制概况 被引量:4

A Survey of Cancer Prevention and Control in Germany
原文传递
导出
摘要 癌症是德国人口的第2位死因,仅次于心血管疾病。2006年,德国有42.7万癌症新发病例,男性以前列腺癌(26.2%)、结直肠癌(15.8%)和肺癌(14.2%)为主;女性以乳腺癌(29.3%)、结直肠癌(16.4%)和肺癌(7.4%)为主。2006年,21万人死于癌症,其中肺癌、结直肠癌和前列腺癌是引起男性死亡的主要癌症,乳腺癌、结直肠癌和肺癌是导致女性死亡的主要癌症。据Robert Koch Institute(RKI)估计,从1980年开始德国每年女性新发癌症病例增加35%,男性增加80%以上,男性和女性年龄标化发病率分别增加15%和23%。吸烟和慢性感染是常见癌症最主要的危险因素。早期检测或筛查项目已在德国实施多年,目的是预防浸润型恶性新发肿瘤的形成和癌症死亡,其中皮肤癌、结肠癌、子宫癌、女性乳腺癌,男性前列腺癌的筛查费用由德国法定健康保险负担。 Cancer ranks the second most frequent causes of death only next to cardiovascular disease in Germany.Four hundred and twenty-seven thousand new cancer cases in 2006 in Germany were found.Prostate cancer(26.2%),colorectum cancer(15.8%),and lung cancer (14.2%) were the most common cancers in males,while breast cancer (29.3%),colo rectum cancer (16.4%),and lung cancer (7.4%) were most common in females.In the current official statistics,210 thousand of cancer-related deaths were reported in Germany in 2006.Among males,lung cancer,colorectum cancer,and prostate cancer,were the major death causes while among females,to breast cancer,colorectum cancer,and lung cancer.According to the current Robert Koch Institute (RKI) estimates,the annual number of new cancer cases in Germany has increased 35% per year in females and more than 80% in males since 1980.The age-standardized incidence rates have increased 15% and 23% among males and females respectively.Tobacco consumption and chronic infections are the most significant risk factors for common cancers.Early-detection or screening programmes have been developed and introduced to prevent the formation of invasive malignant neoplasms,or to prevent death from certain cancers.The screening programmes were provided by statutory health insurance in Germany targeting cancers of the skin,colon,uterus,female breast and male prostate.
出处 《中国肿瘤》 CAS 2011年第6期396-400,共5页 China Cancer
关键词 肿瘤 预防控制 德国 发病率 死亡率 流行病学 neoplasms prevention and control Germany incidence mortality epidemiology
  • 相关文献

参考文献6

  • 1Library of Congress-Federal Research Division.Country profile:Germany. http://memory.loc.gov/frd/cs/profiles/Germany.pdf . 2008
  • 2World Health Organization(WHO). http://www.who.int/countries/deu/en .
  • 3.Health in Germany[]..
  • 4WHO.World Health Organization Statistical Information System:core health indicators. http://apps.who.int/whosis/database/core/core_select.cfm .
  • 5Robert Koch Institute,Federal Statistical Office.Health in Germany[]..2006
  • 6.Cancer in Germany (2005/2006)in-cidence and trends[]..2010

同被引文献27

  • 1吕翠岩,陈信义,唐炳华.青蒿素及其衍生物逆转肿瘤耐药作用初探[J].中国中医药信息杂志,2006,13(4):12-14. 被引量:16
  • 2全国肿瘤防治研究办公室,全国肿瘤登记中心.2010中国肿瘤登记年报[M].北京:军事医学科学出版社,2011:34-38.
  • 3Therese Ericsson,Antje Blank,Cornelia Von Hagens,et al.Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer[J].Eur J Clin Pharmacol,2014,70(12):1453-1463.
  • 4Yang N D,Tan S H,Ng S,et al.Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin[J].The Journal of Biological Chemistry,2014,10(564 567):1-32.
  • 5Serkan Sertel,Tolga Eichhorn,Christian H,et al.Pharmacogenomic identification of c-myc/max-regulated genes associated with cytotoxicity of artesunate towards human colon[J].Ovarian and Lung Cancer Cell Lines,2010,15(5):2886-2910.
  • 6Wai M,Liu P,Andrew M,et al.The antimalaria l agent artesunate possesses anticancer properties that can be enhanced by combination strategies[J].International Journal of Cancer Int,2011,128(5):1471-1480.
  • 7孙雅洁,王京燕.青蒿素及其衍生物体外抗肿瘤活性研究[J].解放军药学学报,2010,26(4):315-317. 被引量:13
  • 8陈万青,张思维,郑荣寿,雷正龙,李光琳,邹小农,赵平.中国肿瘤登记地区2007年肿瘤发病和死亡分析[J].中国肿瘤,2011,20(3):162-169. 被引量:329
  • 9刘亮,左静,李金丫,郭建文,左连富,王静,刘江惠.青蒿琥酯逆转食管癌Eca109/ADM细胞对多柔比星的耐药[J].中国肿瘤生物治疗杂志,2011,18(2):155-159. 被引量:5
  • 10石菊芳,于学勤.澳大利亚肿瘤预防控制概况[J].中国肿瘤,2011,20(5):318-325. 被引量:9

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部